DE69304843T2 - Methode zur Behandlung von Haarausfall - Google Patents

Methode zur Behandlung von Haarausfall

Info

Publication number
DE69304843T2
DE69304843T2 DE69304843T DE69304843T DE69304843T2 DE 69304843 T2 DE69304843 T2 DE 69304843T2 DE 69304843 T DE69304843 T DE 69304843T DE 69304843 T DE69304843 T DE 69304843T DE 69304843 T2 DE69304843 T2 DE 69304843T2
Authority
DE
Germany
Prior art keywords
hair loss
treating hair
alopecia
complexes
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69304843T
Other languages
English (en)
Other versions
DE69304843D1 (de
Inventor
Benjamin Sredni
Michael Albeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69304843D1 publication Critical patent/DE69304843D1/de
Application granted granted Critical
Publication of DE69304843T2 publication Critical patent/DE69304843T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DE69304843T 1992-08-13 1993-07-28 Methode zur Behandlung von Haarausfall Expired - Lifetime DE69304843T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/929,681 US5262149A (en) 1992-08-13 1992-08-13 Method of treating or preventing alopecia

Publications (2)

Publication Number Publication Date
DE69304843D1 DE69304843D1 (de) 1996-10-24
DE69304843T2 true DE69304843T2 (de) 1997-04-10

Family

ID=25458271

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69304843T Expired - Lifetime DE69304843T2 (de) 1992-08-13 1993-07-28 Methode zur Behandlung von Haarausfall

Country Status (7)

Country Link
US (2) US5262149A (de)
EP (1) EP0583026B1 (de)
AT (1) ATE142875T1 (de)
DE (1) DE69304843T2 (de)
DK (1) DK0583026T3 (de)
ES (1) ES2093357T3 (de)
GR (1) GR3021813T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262149A (en) * 1992-08-13 1993-11-16 Benjamin Sredni Method of treating or preventing alopecia
GB9315126D0 (en) * 1993-07-21 1993-09-01 Philips Electronics Uk Ltd Opto-electronic memory systems
DE69534535T2 (de) * 1994-12-15 2006-07-06 Baker Norton Pharmaceuticals, Inc., Miami Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung
US5654328A (en) * 1994-12-15 1997-08-05 Sredni; Benjamin Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
US20050019425A1 (en) * 2001-11-07 2005-01-27 Shiguang Yu Composition and method
US20060258697A1 (en) * 2003-05-13 2006-11-16 Rustum Youcef M Method of augmenting the antitumor activity of anticancer agents
CA2530634A1 (en) * 2003-06-12 2004-12-23 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium and selenium compounds
US7534818B1 (en) * 2003-09-15 2009-05-19 Health Research, Inc. Method of reducing alopecia and bladder toxicity of cyclophosphamide
CA2550459C (en) * 2003-12-18 2009-12-15 Biomas, Ltd. Tellurium derivatives for prevention and treatment of neurodegenerative processes
DE602005008622D1 (de) * 2004-09-17 2008-09-11 Biomas Ltd Neue tellurium-verbindungen und ihre verwendung als immunmodulatoren
CA2580805A1 (en) * 2004-09-17 2006-03-23 Biomas Ltd. Use of tellurium compounds as adjuvants
WO2015008255A2 (en) * 2013-07-17 2015-01-22 Pilogics L.P. Composition, method and kit for formation of galvanic cells on the skin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761490A (en) * 1985-03-15 1988-08-02 Bar-Ilan University Organic derivatives of tellurium and selenium and their use to stimulate cytokine production
US5271925A (en) * 1990-03-09 1993-12-21 Benjamin Sredni Method for protecting against the effects of radiation which is based on the administration of a selenium or tellurium based compound
US5262149A (en) * 1992-08-13 1993-11-16 Benjamin Sredni Method of treating or preventing alopecia

Also Published As

Publication number Publication date
ES2093357T3 (es) 1996-12-16
DK0583026T3 (de) 1997-02-24
DE69304843D1 (de) 1996-10-24
EP0583026B1 (de) 1996-09-18
EP0583026A1 (de) 1994-02-16
US6552089B1 (en) 2003-04-22
ATE142875T1 (de) 1996-10-15
GR3021813T3 (en) 1997-02-28
US5262149A (en) 1993-11-16

Similar Documents

Publication Publication Date Title
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
ATE224714T1 (de) Behandlung von tinnitus mit neuroprotektiven wirkstoffen
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
ATE142875T1 (de) Methode zur behandlung von haarausfall
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
DE69229780T2 (de) Zusammensetzung und methode zur behandlung von störungen in form von depigmentierung
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69004529T2 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE59709081D1 (de) Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
DE59409129D1 (de) Verwendung von lithiumverbindungen zur behandlung und prophylaxe des morbus alzheimer
DE69830811D1 (de) Verwendung von Oxazolidinonderivaten zur Behandlung von Psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition